Jaume Veciana, Scientific Director of NANBIOSIS; Director of Molecular Nanosciences and Organic Materials Dpt. (ICMAB-CSIC) and Coordinator of Platform Programme of CIBER BBN.
Francisco Miguel Sánchez Margallo; Assistant Director of NANBIOSIS and Scientific Director of JUMISC
Ramón Martínez Máñez, PI of the Group of Applied Molecular Chemistry Center of Molecular Recognition and Technological Development of the Polytechnic University of Valencia (UPV-ADM-IQMA) Scientific Director of CIBER-BBN
Raquel Ruiz Hidalgo; R&D&i Coordinator of JUMISC. Deputy Coordinator of NANBIOSIS
Jesús Mª Izco Zaratiegui; Responsible for Infrastructures and Research Services of CIBER BBN. Coordinator of NANBIOSIS
Leif Sörnmo (Lund Institute of TechnologyLund University, Sweden)
Matthias Epple (Inorganic Chemistry, University of Duisburg-Essen, Germany)
Patrick Boisseau (ETPN Chair Executive Board, CEA-Leti, Grenoble, France)
Miguel Angel de Gregorio (Prof. of Interventional Radiology, University of Zaragoza)
Virginio García Martínez (University of Extremadura, Spain)
Hector Ferral. (Department of Radiology, Section of Interventional Radiology, NorthShore University HealthSystem)
Mª Eugenia Fernández Santos, (Director of Cellular Production Unit and Regenerative Medicine, Director of GMP facilities of Hospital Gregorio Marañón)
Scientific-Technical Advisory Committee
Niilo Saranummi (VTT Technical Research Centre of Finland).
Joan Bigorra, Innovation Director of the Hospital Clinic of Barcelona.
Enrique Gómez Barrena, Medical Specialist of Trauma and Orthopaedics Area at the University Hospital La Paz.
Josep Tabernero Caturla, Coordinator of Onco-Hematology at the Vall d’Hebron Hospital.
Antonio Bernad,, Research Proffessor at Immunology and Onocology Department, National Center for Biotechnology (CNB).
Manuel Sarasa, Professor of Comparative Anatomy and Pathological Anatomy at the University of Zaragoza, Scientific Director of Araclon Biotech S.L.
Begoña Castro, Scientific Director of Histocell.
Pilar Calvo, Pharmaceutical Development Manager of PHARMAMAR.
Ignacio Santiago Álvarez, Professor of the University of Extremadura / Scientific Director IERA-GC, Badajoz.
Francisco Fernández Avilés, Chair of the Department of Cardiology, University Hospital Gregorio Marañón, Madrid.